| Literature DB >> 32410582 |
Xiuying Wang1, Lin Zhuo2, Yifei Ma3, Ting Cai3, Aviva Must4, Ling Xu5, Lang Zhuo6.
Abstract
BACKGROUND: Health-related quality of life (HRQoL) is often measured using EQ-5D-3L by the elicitation methods of visual analogue scale (VAS) and time trade-off (TTO). Although many countries have constructed both national VAS and TTO value sets, the fact that VAS and TTO value sets produces different values bewilders researchers and policymakers. The aim of this study is to explore certain conditions which could yield similar value sets using VAS and TTO.Entities:
Keywords: EQ-5D-3L; Quality of life measurement; Time trade-off (TTO); Valuation method; Visual analogue scale (VAS)
Mesh:
Year: 2020 PMID: 32410582 PMCID: PMC7227357 DOI: 10.1186/s12874-020-01008-9
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
18 health states created by orthogonal design (L18,2*3^7)
| State number | Mobility | Self-Care | Usual Activities | Pain/Discomfort | Anxiety/Depression |
|---|---|---|---|---|---|
| 1 | 1 | 1 | 1 | 1 | 1 |
| 2 | 3 | 1 | 1 | 2 | 2 |
| 3 | 2 | 2 | 1 | 1 | 3 |
| 4 | 1 | 3 | 2 | 1 | 2 |
| 5 | 1 | 2 | 3 | 2 | 1 |
| 6 | 2 | 1 | 2 | 3 | 1 |
| 7 | 2 | 2 | 2 | 2 | 2 |
| 8 | 2 | 3 | 3 | 1 | 1 |
| 9 | 1 | 1 | 3 | 3 | 2 |
| 10 | 3 | 2 | 1 | 3 | 1 |
| 11 | 3 | 1 | 2 | 1 | 3 |
| 12 | 1 | 3 | 1 | 2 | 3 |
| 13 | 1 | 2 | 2 | 3 | 3 |
| 14 | 3 | 3 | 2 | 2 | 1 |
| 15 | 2 | 1 | 3 | 2 | 3 |
| 16 | 2 | 3 | 1 | 3 | 2 |
| 17 | 3 | 2 | 3 | 1 | 2 |
| 18 | 3 | 3 | 3 | 3 | 3 |
The numbers 1, 2, and 3 in five dimensions represent level 1 (no problem), level 2 (moderate problem) and level 3 (severe problem), respectively
Definition of dummy variables and model specification
| Dummy variables | Definition | |
|---|---|---|
| MO2 | 1 if mobility is level 2; 0 otherwise | |
| SC2 | 1 if self-care is level 2; 0 otherwise | |
| UA2 | 1 if usual activities is level 2; 0 otherwise | |
| PD2 | 1 if pain/discomfort is level 2; 0 otherwise | |
| AD2 | 1 if anxiety/depression is level 2; 0 otherwise | |
| MO3 | 1 if mobility is level 3; 0 otherwise | |
| SC3 | 1 if self-care is level 3; 0 otherwise | |
| UA3 | 1 if usual activities is level 3; 0 otherwise | |
| PD3 | 1 if pain/discomfort is level 3; 0 otherwise | |
| AD3 | 1 if anxiety/depression is level 3; 0 otherwise | |
| N3 | 1 if at least one level 3; 0 otherwise | |
| constant | loss of utility of any health state away from full health | |
| Model 1 | VAS model with constant and N3 | |
| Model 2 | TTO model with constant and N3 | |
| Model 3 | VAS model without constant and N3 | |
| Model 4 | TTO model without constant and N3 |
Mean, standard deviation, median and quartiles for rescaled VAS and TTO values (n = 313)
| States | VAS | TTO | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean | Std. Deviation | P25 | P50 | P75 | Mean | Std. Deviation | P25 | P50 | P75 | |
| 11111 | 1.0000 | 0.0000 | 1 | 1 | 1 | 1.0000 | 0.0000 | 1 | 1 | 1 |
| 31122 | 0.6874 | 0.1628 | 0.6 | 0.7 | 0.8 | 0.6125 | 0.1685 | 0.5 | 0.6 | 0.7 |
| 22113 | 0.5679 | 0.1858 | 0.4 | 0.6 | 0.7 | 0.5193 | 0.1613 | 0.4 | 0.5 | 0.6 |
| 13212 | 0.6178 | 0.1797 | 0.5 | 0.6 | 0.7 | 0.4867 | 0.1632 | 0.4 | 0.5 | 0.6 |
| 12321 | 0.5882 | 0.1577 | 0.5 | 0.6 | 0.7 | 0.5025 | 0.1465 | 0.4 | 0.5 | 0.6 |
| 21231 | 0.5171 | 0.1377 | 0.4 | 0.5 | 0.6 | 0.4816 | 0.1383 | 0.4 | 0.5 | 0.5 |
| 22222 | 0.4613 | 0.1468 | 0.4 | 0.5 | 0.5 | 0.4155 | 0.1556 | 0.3 | 0.4 | 0.5 |
| 23311 | 0.4451 | 0.1387 | 0.4 | 0.4 | 0.5 | 0.4300 | 0.1483 | 0.4 | 0.4 | 0.5 |
| 11332 | 0.4300 | 0.1454 | 0.3 | 0.4 | 0.5 | 0.4503 | 0.1446 | 0.4 | 0.5 | 0.5 |
| 32131 | 0.3962 | 0.1422 | 0.3 | 0.4 | 0.5 | 0.3963 | 0.1486 | 0.3 | 0.4 | 0.5 |
| 31213 | 0.4962 | 0.1857 | 0.4 | 0.5 | 0.6 | 0.3980 | 0.1450 | 0.3 | 0.4 | 0.5 |
| 13123 | 0.4553 | 0.1307 | 0.4 | 0.5 | 0.6 | 0.4426 | 0.1431 | 0.4 | 0.5 | 0.5 |
| 12233 | 0.4335 | 0.1921 | 0.3 | 0.4 | 0.6 | 0.3842 | 0.1941 | 0.3 | 0.4 | 0.5 |
| 33221 | 0.4764 | 0.2063 | 0.3 | 0.4 | 0.6 | 0.3835 | 0.1412 | 0.3 | 0.4 | 0.4 |
| 21323 | 0.4006 | 0.1817 | 0.3 | 0.4 | 0.6 | 0.3647 | 0.1381 | 0.3 | 0.4 | 0.4 |
| 23132 | 0.3946 | 0.2201 | 0.2 | 0.4 | 0.5 | 0.2794 | 0.1550 | 0.2 | 0.2 | 0.3 |
| 32312 | 0.3884 | 0.2301 | 0.2 | 0.4 | 0.5 | 0.2904 | 0.1428 | 0.2 | 0.3 | 0.3 |
| 33333 | −0.1378 | 0.2465 | −0.2 | −0.1 | 0 | −0.0801 | 0.1509 | −0.125 | −0.1 | −0.028 |
| Total | 0.4788 | 0.2703 | 0.3 | 0.5 | 0.6 | 0.4310 | 0.2457 | 0.3 | 0.4 | 0.5 |
Coefficients and indices of the goodness-of-fit of VAS and TTO models
| Model 1 (VAS) | Model 2 (TTO) | Model 3 (VAS) | Model 4 (TTO) | |
|---|---|---|---|---|
| 11111 | 1 | 1 | 1 | 1 |
| constant | − 0.0299 | − 0.0141 | – | – |
| MO2 | − 0.1154 | − 0.1292 | − 0.1158 | − 0.1340 |
| MO3 | −0.2180 | − 0.2058 | − 0.2111 | −0.2159 |
| SC2 | −0.1060 | − 0.1329 | − 0.1064 | −0.1377 |
| SC3 | −0.2172 | −0.2220 | − 0.2103 | −0.2321 |
| UA2 | −0.0879 | −0.1170 | − 0.0884 | −0.1218 |
| UA3 | −0.2413 | −0.2103 | − 0.2345 | −0.2205 |
| PD2 | −0.0767 | −0.0673 | − 0.0772 | −0.0721 |
| PD3 | −0.2553 | −0.1967 | − 0.2484 | −0.2068 |
| AD2 | −0.0646 | −0.1096 | − 0.0650 | −0.1145 |
| AD3 | −0.2087 | −0.1893 | − 0.2018 | −0.1994 |
| N3 | 0.0439 | −0.0318 | – | – |
| Adj. R-square | 0.9409 | 0.9499 | 0.9550 | 0.9664 |
| AIC | − 5285.48 | − 6918.29 | − 5252.47 | − 6876.14 |
| BIC | − 5192.57 | − 6825.38 | − 5172.83 | − 6796.50 |
| MAE | 0.0304 | 0.0269 | 0.0327 | 0.0310 |
| # > 0.05 | 4 | 1 | 4 | 4 |
| # > 0.1 | 0 | 0 | 0 | 0 |
| r | 0.9847 | 0.9879 | 0.9813 | 0.9867 |
| Logical error num. | 0 | 0 | 0 | 0 |
All models and regression coefficients were significant (P < 0.05); Adj. R-square adjusted R-square, AIC Akaike information criterion, BIC Bayesian information criterion, MAE mean absolute error between observed mean and predicted value # > 0.05, number of MAE > 0.05 out of 18 states; # > 0.1, number of MAE > 0.1 out of 18 states, r,correlation coefficient between observed means and predicted values, Logical error num., number of inconsistencies among all predicted health state values
Fig. 1a Curves of Model 1 and Model 2 perform similarly, b Curves of Model 3 and Model 4 perform more similarly, c Curves of UK VAS and UK TTO cross over each other, d Curves of Sweden VAS is lower than Sweden TTO